Chris Tran

11.9k total citations · 6 hit papers
23 papers, 8.7k citations indexed

About

Chris Tran is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Chris Tran has authored 23 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Genetics. Recurrent topics in Chris Tran's work include Cancer, Hypoxia, and Metabolism (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Estrogen and related hormone effects (5 papers). Chris Tran is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Estrogen and related hormone effects (5 papers). Chris Tran collaborates with scholars based in United States, Russia and Germany. Chris Tran's co-authors include Charles L. Sawyers, Derek S. Welsbie, Robert L. Vessella, Ingo K. Mellinghoff, Michael G. Rosenfeld, Sung Hee Baek, Ping Chen, Francis Y. Lee, Neil P. Shah and Derek Norris and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Chris Tran

23 papers receiving 8.5k citations

Hit Papers

Molecular determinants of resistance to antiandrogen therapy 1998 2026 2007 2016 2003 2009 2004 2001 1998 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Molecular determinants of resistance to antiandrogen therapy
    2003 1.8k citations Derek S. Welsbie, Chris Tran et al. Nature Medicine profile →
  2. Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
    2009 1.7k citations Chris Tran, Samedy Ouk et al. Science profile →
  3. Overriding Imatinib Resistance with a Novel ABL Kinase Inhibitor
    2004 1.4k citations Chris Tran, Charles L. Sawyers et al. Science profile →
  4. Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR
    2001 806 citations Ingo K. Mellinghoff, Chris Tran et al. Proceedings of the National Academy of Sciences profile →
  5. Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression
    1998 526 citations Young E. Whang, Xinyi Wu et al. Proceedings of the National Academy of Sciences profile →
  6. Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer
    2005 507 citations George Thomas, Chris Tran et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chris Tran United States 20 4.4k 4.0k 1.9k 1.7k 1.3k 23 8.7k
Gideon Bollag United States 51 10.1k 2.3× 1.3k 0.3× 1.1k 0.6× 4.6k 2.7× 694 0.5× 124 14.7k
Heidi A. Lane Switzerland 47 9.7k 2.2× 2.9k 0.7× 2.1k 1.1× 5.9k 3.5× 430 0.3× 113 14.6k
David T. Hung United States 17 2.2k 0.5× 2.3k 0.6× 1.8k 1.0× 759 0.4× 3.4k 2.7× 24 7.1k
Rileen Sinha United States 11 8.5k 1.9× 3.2k 0.8× 4.2k 2.2× 4.3k 2.6× 279 0.2× 18 13.2k
Yevgeniy Antipin United States 5 9.3k 2.1× 3.3k 0.8× 4.3k 2.3× 3.9k 2.3× 388 0.3× 6 13.7k
Valeria R. Fantin United States 32 6.9k 1.6× 882 0.2× 4.8k 2.5× 1.5k 0.9× 1.3k 1.0× 55 11.0k
Roel G.W. Verhaak United States 42 8.0k 1.8× 4.3k 1.1× 5.3k 2.8× 3.7k 2.2× 1.4k 1.1× 95 13.5k
Olle Larsson Sweden 51 4.4k 1.0× 2.2k 0.6× 1.3k 0.7× 2.5k 1.5× 203 0.2× 212 8.5k
Francesco Hofmann Switzerland 30 4.2k 1.0× 900 0.2× 1.0k 0.5× 1.4k 0.9× 429 0.3× 56 5.9k
John Wongvipat United States 23 3.3k 0.7× 5.1k 1.3× 2.0k 1.0× 1.6k 1.0× 256 0.2× 35 7.4k

Countries citing papers authored by Chris Tran

Since Specialization
Citations

This map shows the geographic impact of Chris Tran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Tran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Tran more than expected).

Fields of papers citing papers by Chris Tran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Tran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Tran. The network helps show where Chris Tran may publish in the future.

Co-authorship network of co-authors of Chris Tran

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Tran. A scholar is included among the top collaborators of Chris Tran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Tran. Chris Tran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jing, Ju Liu, Xuemei Zhang, et al.. (2021). Nonclinical Pharmacokinetics and Absorption, Distribution, Metabolism, and Excretion of Givosiran, the First Approved N-Acetylgalactosamine–Conjugated RNA Interference Therapeutic. Drug Metabolism and Disposition. 49(7). 572–580. 29 indexed citations
2.
Liu, Ju, Jing Li, Chris Tran, et al.. (2019). Oligonucleotide Quantification and Metabolite Profiling by High-Resolution and Accurate Mass Spectrometry. Bioanalysis. 11(21). 1967–1980. 30 indexed citations
3.
Li, Jing, Chris Tran, Krishna Aluri, et al.. (2019). Discovery of a Novel Deaminated Metabolite of a Single-Stranded Oligonucleotide In Vivo by Mass Spectrometry. Bioanalysis. 11(21). 1955–1965. 17 indexed citations
4.
Zhou, Haiying, Mallika Singh, Chris Tran, et al.. (2017). Abstract 4172: Activation of AR signaling by mifepristone enhances prostate cancer growth and impairs enzalutamide response. Cancer Research. 77(13_Supplement). 4172–4172. 4 indexed citations
5.
Jung, Michael E., Samedy Ouk, Dongwon Yoo, et al.. (2010). Structure−Activity Relationship for Thiohydantoin Androgen Receptor Antagonists for Castration-Resistant Prostate Cancer (CRPC). Journal of Medicinal Chemistry. 53(7). 2779–2796. 206 indexed citations
6.
Tran, Chris, Samedy Ouk, Nicola J. Clegg, et al.. (2009). Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer. Science. 324(5928). 787–790. 1689 indexed citations breakdown →
7.
Vivanco, Igor, Nicolaos Palaskas, Chris Tran, et al.. (2007). Identification of the JNK Signaling Pathway as a Functional Target of the Tumor Suppressor PTEN. Cancer Cell. 11(6). 555–569. 199 indexed citations
8.
Fueger, Barbara J., Johannes Czernin, Isabel J. Hildebrandt, et al.. (2006). Impact of animal handling on the results of 18F-FDG PET studies in mice.. PubMed. 47(6). 999–1006. 372 indexed citations
9.
Thomas, George, Chris Tran, Ingo K. Mellinghoff, et al.. (2005). Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer. Nature Medicine. 12(1). 122–127. 507 indexed citations breakdown →
10.
Kim, Jung Hwa, Ling Cai, Hee June Choi, et al.. (2005). Transcriptional regulation of a metastasis suppressor gene by Tip60 and β-catenin complexes. Nature. 434(7035). 921–926. 251 indexed citations
11.
Waldherr, Christian, Ingo K. Mellinghoff, Chris Tran, et al.. (2005). Monitoring antiproliferative responses to kinase inhibitor therapy in mice with 3'-deoxy-3'-18F-fluorothymidine PET.. PubMed. 46(1). 114–20. 82 indexed citations
12.
Mellinghoff, Ingo K., Igor Vivanco, Andrew Kwon, et al.. (2004). HER2/neu kinase-dependent modulation of androgen receptor function through effects on DNA binding and stability. Cancer Cell. 6(5). 517–527. 262 indexed citations
13.
Gera, Joseph, Ingo K. Mellinghoff, Yijiang Shi, et al.. (2004). AKT Activity Determines Sensitivity to Mammalian Target of Rapamycin (mTOR) Inhibitors by Regulating Cyclin D1 and c-myc Expression. Journal of Biological Chemistry. 279(4). 2737–2746. 284 indexed citations
14.
Ngo, Tung H., R. James Barnard, Chris Tran, et al.. (2004). Effect of Isocaloric Low-Fat Diet on Prostate Cancer Xenograft Progression to Androgen Independence. Cancer Research. 64(4). 1252–1254. 34 indexed citations
15.
Welsbie, Derek S., Chris Tran, Sung Hee Baek, et al.. (2003). Molecular determinants of resistance to antiandrogen therapy. Nature Medicine. 10(1). 33–39. 1796 indexed citations breakdown →
16.
Berger, Frank, et al.. (2003). MicroPET imaging of prostate cancer in LNCAP‐SR39TK‐GFP mouse xenografts. The Prostate. 55(1). 39–47. 24 indexed citations
17.
Ngo, Tung H., R. James Barnard, Pinchas Cohen, et al.. (2003). Effect of isocaloric low-fat diet on human LAPC-4 prostate cancer xenografts in severe combined immunodeficient mice and the insulin-like growth factor axis.. PubMed. 9(7). 2734–43. 69 indexed citations
18.
Mellinghoff, Ingo K., Chris Tran, & Charles L. Sawyers. (2002). Growth inhibitory effects of the dual ErbB1/ErbB2 tyrosine kinase inhibitor PKI-166 on human prostate cancer xenografts.. PubMed. 62(18). 5254–9. 70 indexed citations
19.
Whang, Young E., Chris Tran, Randi G. Syljuåsen, et al.. (2000). c-Abl is required for development and optimal cell proliferation in the context of p53 deficiency. Proceedings of the National Academy of Sciences. 97(10). 5486–5491. 24 indexed citations
20.
Whang, Young E., Xinyi Wu, Hiroyoshi Suzuki, et al.. (1998). Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression. Proceedings of the National Academy of Sciences. 95(9). 5246–5250. 526 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gideon Bollag Breakdown of academic impact, for papers by Heidi A. Lane Breakdown of academic impact, for papers by David T. Hung Breakdown of academic impact, for papers by Rileen Sinha Breakdown of academic impact, for papers by Yevgeniy Antipin Breakdown of academic impact, for papers by Valeria R. Fantin Breakdown of academic impact, for papers by Roel G.W. Verhaak Breakdown of academic impact, for papers by Olle Larsson Breakdown of academic impact, for papers by Francesco Hofmann Breakdown of academic impact, for papers by John Wongvipat
Rankless by CCL
2026